SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000489
Filing Date
2024-01-26
Accepted
2024-01-26 17:00:16
Documents
12
Period of Report
2024-01-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 26478
  Complete submission text file 0001683168-24-000489.txt   199342

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phio-20240124.xsd EX-101.SCH 3021
3 XBRL LABEL FILE phio-20240124_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE phio-20240124_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3326
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 24568734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)